Institution scientifique

Instituto Nazionale Tumori Regina Elena

Rome · IT · facility

1157Publications signalées

72200Citations signalées

12Thèmes principaux

Principaux domaines

Cancer Treatment and PharmacologyLung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersBreast Cancer Treatment StudiesColorectal Cancer Treatments and StudiesCancer Genomics and DiagnosticsHER2/EGFR in Cancer ResearchImmunotherapy and Immune ResponsesAdvanced Breast Cancer TherapiesSarcoma Diagnosis and TreatmentGastric Cancer Management and OutcomesLung Cancer Diagnosis and Treatment

Évolution annuelle

199019

199122

199424

199524

199633

199831

200025

200338

200432

200535

200643

200749

200828

200953

201023

201128

201231

201323

201427

201528

201629

201747

201834

201943

202035

202139

202239

202337

202424

202525

Publications récentes

Accès ouvert 2026 erratumOpenAlex

Corrigendum to ’Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study’ [Cancer Treat Res Commun. 2026:47:101143]

Paolo Bironzo, Alessandro Morabito, Sonia Silipigni, Vincenzo Adamo et autres

0 citationsCancer Treatment and Research Communications

Accès ouvert 2026 conference-abstractOpenAlex

ALKOVE-1: Efficacy and safety of neladalkib in patients with advanced ALK + NSCLC.

Jessica Jiyeong Lin, Enriqueta Felip, B K Cho, B Besse et autres

1 citationJournal of Clinical Oncology

2026 conference-abstractOpenAlex

Clinical significance of EGFR amplification in patients with EGFR -mutated metastatic non–small cell lung cancer receiving first-line osimertinib.

Alessandro Di Federico, Federica Pecci, Mark Jeng, M. Peroni et autres

0 citationsJournal of Clinical Oncology

2026 conference-abstractOpenAlex

A phase 3 study of sacituzumab govitecan in patients with previously treated extensive-stage small cell lung cancer.

Afshin Dowlati, Myung-Ju Ahn, Alan A. Azambuja, Lauren Averett Byers et autres

0 citationsJournal of Clinical Oncology

Accès ouvert 2026 articleOpenAlex

507P Biomarker assessment in ROS1+ NSCLC

Andrea Torchia, Gabriele Minuti, M. Giammaruco, Corrado Orciuolo et autres

0 citationsESMO Open

2026 articleOpenAlex

Predictors of acute Lymphopenia after radiotherapy for prostate cancer including pelvic node irradiation: results of a prospective multi-centric study

M. Pavarini, V. Vavassori, L. Alborghetti, S. Aimonetto et autres

0 citationsPhysica Medica

2026 articleOpenAlex

Assessment of variability in performances of scanners for functional MRI with spin echo epi acquisition sequence – preliminary results of a large multicenter intercomparison phantom study

G. Belmonte, M. Maieron, L. Altabella, E. Balboni et autres

0 citationsPhysica Medica

Accès ouvert 2026 articleOpenAlex

Predictors of acute lymphopenia after radiotherapy for prostate cancer including pelvic node irradiation: results of a real-world prospective multi-centric study

V. Vavassori, Maddalena Pavarini, Lisa Alborghetti, Stefania Aimonetto et autres

0 citationsESMO Real World Data and Digital Oncology

Accès ouvert 2026 preprintOpenAlex

Efficacy and safety of subcutaneous and intravenous administration of atezolizumab in patients with locally advanced or metastatic non-small cell lung cancer: final results of the IMscin001 and IMscin002 randomized studies

Mauricio Burotto, Zanete Zvirbule, Renzo Alvarez, Busyamas Chewaskulyong et autres

0 citationsSSRN Electronic Journal

Accès ouvert 2025 articleOpenAlex

Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations

Tianshi Lu, Habib Hamidi, Mark A. Socinski, Martin Reck et autres

5 citationsNature Communications

Accès ouvert 2025 articleOpenAlex

Angiotensin II, miR-34a, and AGTRAP crosstalk in arterial smooth muscle cells

Maria Cristina Florio, Sara Sileno, Liqun Jiang, M D'agostino et autres

1 citationGeroScience

2025 articleOpenAlex

An Exploratory Survey on the Use of Anal Cytology as a Tool for Anal Cancer Screening in Italy

Maria Gabriella Donà, Antonella Pellegrini, Francesca Rollo, Valentina Laquintana et autres

0 citationsCancer Prevention Research

Identifiant ROR

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.